세계의 두개내 스텐트 시장 : 시장 규모(적응증별, 제품 유형별, 최종사용자별, 지역별), 예측

Intracranial Stents Market Size And Forecast

Intracranial Stents Market size was valued at USD 437.17 Million in 2024 and is projected to reach USD 848.96 Million by 2032, growing at a CAGR of 8.65% from 2026 to 2032.

Intracranial stents are small, tube-like medical devices that are implanted within the brain's blood vessels to treat a variety of cerebrovascular disorders, particularly those characterized by irregular blood flow or narrowed arteries. These stents are often made of biocompatible materials like nitinol or cobalt-chromium alloy and can either self-expand or expand with a balloon. They are utilized to offer structural support to less effective or restricted arteries, keeping them open and allowing enough blood flow to brain areas. This technique is critical for preventing strokes, repairing aneurysms, and managing diseases like cerebral atherosclerosis.

Intracranial stents are used to treat a variety of medical disorders. The treatment of cerebral aneurysms is when stents are used to maintain the vascular wall and prevent rupture. They are also used to manage ischemic stroke, particularly when mechanical thrombectomy is required to remove a blood clot. Furthermore, intracranial stents play an important role in the treatment of cerebral artery stenosis by widening limited arteries and restoring normal blood flow. These stents are used with modern imaging techniques, such as angiography, to ensure exact placement and effectiveness in restoring vascular integrity.

Advancements in material science, imaging technologies, and minimally invasive surgery. Innovations are likely to focus on developing stents with improved biocompatibility and drug-eluting capabilities to lower the risk of restenosis and thrombosis. Furthermore, incorporating smart technology into stents, such as sensors for real-time monitoring of blood flow and vessel status, has the potential to transform patient care by giving continuous data and allowing for proactive management of cerebrovascular illnesses. As research advances, the use of cerebral stents is projected to grow, providing better outcomes for patients with a broader spectrum of neurovascular disorders and potentially expanding their usage to new therapeutic areas.

Global Intracranial Stents Market Dynamics

The key market dynamics that are shaping the global intracranial stents market include:

Key Market Drivers:

Rising Incidence of Cerebrovascular Diseases: The increasing incidence of cerebrovascular diseases, including stroke and atherosclerosis, is driving the intracranial stents market. As the world's population ages, the prevalence of these disorders increases, need modern medical techniques such as intracranial stenting to properly manage and treat them. This tendency is especially evident in affluent countries with aging populations, where the demand for effective cerebrovascular treatments is quickly increasing.

Advancements in Medical Imaging Technology: Medical imaging technology, such as high-resolution MRI and CT angiography, has transformed the identification and treatment of cerebrovascular diseases. Enhanced imaging enables more precise implantation of intracranial stents, improving their efficacy and safety. This technological advancement has facilitated the use of intracranial stenting treatments because clinicians can now better observe and navigate intricate cerebral arteries, lowering procedural risks and increasing patient outcomes.

Technological Innovations in Stent Design: New developments in stent design, such as the emergence of drug-eluting and bioresorbable stents, are moving the intracranial stents market ahead. These developments seek to improve stent efficacy, lower the risk of restenosis, and improve long-term patient outcomes. The arrival of new materials and designs with improved biocompatibility and flexibility has boosted the use of intracranial stents, making treatments more successful and expanding the patient pool.

Supportive Government Initiatives and Policies: These policies aimed at improving healthcare outcomes are driving growth in the intracranial stents market. Programs that fund research and development, give subsidies for innovative medical devices, and improve public healthcare systems all contribute to the rising use of intracranial stents. These policies not only promote market expansion but also ensure that a larger portion of the public has access to cutting-edge cerebrovascular treatments.

Key Challenges:

Complexity of Patient Selection: To select appropriate candidates for intracranial stenting, several aspects must be considered, including lesion morphology, vascular anatomy, and comorbidities. The difficulty of patient selection criteria can limit the broad use of intracranial stents, necessitating extensive review to optimize treatment outcomes.

Skill and Training Requirements: Neurointerventionalists must have different expertise and training to perform intracranial stenting, which includes advanced imaging techniques and catheter-based treatments. The scarcity of skilled personnel can impede widespread adoption and quality assurance.

Emerging Alternatives and Technologies: Advancements in alternative therapies, such as flow diverters and surgical procedures, pose competitive threats to intracranial stenting. To remain commercially relevant in the ever-changing landscape of cerebrovascular therapies, stent technology must be constantly innovated and adaptable.

Risk of Complications and Adverse Events: Risks associated with intracranial stenting procedures include thrombosis, bleeding, and blood vessel perforation which can cause severe neurological consequences. Managing these risks necessitates the use of highly skilled practitioners and specialized facilities, making it difficult to ensure consistent safety and efficacy across diverse patient populations.

Key Trends:

Integration of Drug-Eluting Technologies: The development of drug-eluting intracranial stents intends to reduce restenosis by releasing therapeutic drugs directly at the treatment site, with the potential for improved long-term efficacy over bare-metal stents.

Emerging Markets and Accessible Healthcare: Growing healthcare infrastructure and rising disposable budgets in emerging nations are encouraging increased adoption of intracranial stents, hence improving access to modern cerebrovascular treatments.

Regulatory Advancements and Standardization: Efforts to streamline regulatory channels and develop consistent recommendations for intracranial stent use drive market growth by guaranteeing device safety, efficacy, and quality in both production and clinical practice.

Personalized Medicine Approaches: Advances in genetic profiling and biomarker discovery are opening the way for individualized treatment options with intracranial stents that are matched to individual patient characteristics and illness profiles.

Global Intracranial Stents Market Regional Analysis

Here is a more detailed regional analysis of the global intracranial stents market:

North America:

North America dominates the global intracranial stents market, thanks to its strong healthcare infrastructure and broad use of new medical technology. The region benefits from a mature ecosystem of healthcare providers and research institutes that specialize in neurovascular treatments.

Major intracranial stent manufacturers are located or have large operations in North America, which promotes innovation and ensures access to cutting-edge therapies. The high frequency of cerebrovascular illnesses and neurological disorders, combined with robust regulatory frameworks that support medical device approvals, reinforces North America's dominance in the intracranial stents industry.

According to the Medicare Coverage Database, the intracranial arteries contribute to 8-10% of all ischemic strokes in the United States (Thijs et al., 2000). Intracranial artery stenosis is responsible for around 70,000 to 90,000 strokes or transient ischemic episodes (TIAs) per year (Chimowitz et al., 2005). The major intracranial arteries are the anterior and middle cerebral arteries, the basilar artery, and the vertebral artery's intracranial parts.

Asia Pacific:

The Asia Pacific region's intracranial stents market is expected to grow rapidly due to a combination of demographic and economic factors. A growing population with higher healthcare requirements, combined with rising occurrences of cerebrovascular illnesses and neurological problems, drives demand for improved neuro interventional treatments such as intracranial stenting. Furthermore, there is a growing awareness of preventive healthcare practices, which promote early detection and intervention, increasing the region's use of intracranial stents.

The growing middle class in Asia Pacific countries contributes significantly to market growth. With more disposable income, this demographic group desires access to modern medical technologies and procedures, such as intracranial stenting.

Increasing expenditures in healthcare infrastructure and the construction of specialist neurology clinics are improving access to neuro interventional operations, meeting Asia Pacific's growing demand for effective cerebrovascular therapies. These factors highlight the region's emergence as a key growth hub in the intracranial stents market.

Global Intracranial Stents Market: Segmentation Analysis

The Global Intracranial Stents Market is Segmented on the basis of Disease Indication, Product Type, End-User, And Geography.

Intracranial Stents Market, By Disease Indication

• Brain Aneurysm
• Intracranial Stenosis

Based on Disease Indication, the market is fragmented into Brain Aneurysm and Intracranial Stenosis. In the Intracranial Stents market, Intracranial Stenosis is expected to be the fastest-expanding category. This is being driven by the increasing prevalence of cerebrovascular disorders, which are a key risk factor for stenosis. Increased awareness and developments in diagnostic tools are allowing for earlier detection of stenosis, necessitating the insertion of stents to prevent stroke. Brain aneurysms are anticipated to have the largest share due to proven treatment approaches including stents, although stenosis is growing at a quicker rate due to an expanding pool of patients requiring this treatment.

Intracranial Stents Market, By Product Type

• Stent-Assisted Coil Embolization
• Balloon Expanding Stents
• Self-Expanding Stents

Based on Product Type, the market is segmented into Stent-Assisted Coil Embolization, Balloon Expanding Stents, and Self-Expanding Stents.

• Self-expanding stents are likely to take over due to their ease of use and adaptability to a variety of vessel geometries. However, balloon-expanding stents are predicted to be the most rapidly developing category. This is because they provide accurate positioning and improved control during deployment, which is increasingly important for complex processes.

Intracranial Stents Market, By End-User

• Hospitals
• Ambulatory Surgical Centers

Based on End-Users, the market is segmented into Hospitals and Ambulatory Surgical Centers. Hospitals are now the dominant segment in the intracranial stents market, owing to their well-equipped facilities and specialist surgeons for difficult intracranial stent surgeries. However, ambulatory surgery facilities are likely to be the most rapidly developing segment. Advances in minimally invasive stent installation techniques, combined with rising costs, have made these facilities a more cost-effective choice for certain procedures.

Intracranial Stents Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Intracranial Stents Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to be the dominating area in the intracranial stents market. This is due to a mix of variables, including high healthcare costs, established infrastructure, and a big patient population with cerebrovascular illnesses. Asia Pacific is likely to experience the most rapid expansion. Rising disposable incomes, more understanding of stroke prevention, and an aging population making these conditions more likely all contribute to this trend.

Key Players

The "Global Intracranial Stents Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Boston Scientific Corporation, DePuy Synthes, Penumbra, Inc., Medtronic, Terumo Corporation, Phenox, Acandis, Stryker Corporation, Cook Medical, and MicroPort Scientific. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Intracranial Stents Market Recent Developments
• In September 2022, Phenox GmbH launched the pEGASUS HPC stent globally at the ESMINT 2022 congress in Nice, France. The pEGASUS HPC stent is the first stent of its kind to introduce coating technology for the treatment of ICAD and aneurysms.
• In June 2022, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, announced a CE- certified fourth-generation flow diverter, PipelineTM Vantage with Shield Technology for endovascular treatment of brain aneurysms

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRACRANIAL STENTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL INTRACRANIAL STENTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL INTRACRANIAL STENTS MARKET, BY DISEASE INDICATION

• 5.1 Overview
• 5.2 Brain Aneurysm
• 5.3 Intracranial Stenosis

6 GLOBAL INTRACRANIAL STENTS MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Stent-Assisted Coil Embolization
• 6.3 Balloon Expanding Stents
• 6.4 Self-Expanding Stents

7 GLOBAL INTRACRANIAL STENTS MARKET, BY END USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Others

8 GLOBAL INTRACRANIAL STENTS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East

9 GLOBAL INTRACRANIAL STENTS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Boston Scientific Corporation
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 DePuy Synthes
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Medtronic
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Terumo Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Phenox
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Acandis
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Stryker Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Cook Medical
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 MicroPort Scientific
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research